Pharmafile Logo
Pharmafocus logo
Advanced Search

Merck KGaA

Showing 15 posts of 91 posts found.

Merck KGaA appoints new heads of corporate auditing and strategy

December 2, 2011
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Merck KGaA

Merck KGaA has appointed Dr Friederike Rotsch as its new head of corporate auditing. She reports to Karl-Ludwig Kley, chairman …

Appointment
Merck Facebook

Merck and Merck look to settle Facebook naming dispute

November 29, 2011
Medical Communications Facebook, Merck, Merck KGaA

Merck & Co and Merck KGaA looked to have made inroads into their Facebook naming quarrel. Earlier this month Merck …

News

Joachim Christ to lead corporate controlling at Merck KGaA

November 15, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck KGaA

Joachim Christ will join Merck KGaA on 1 January next year as its new head of corporate controlling. Christ, 46, …

Appointment
Merck Serono

Merck KGaA signs MS and cancer research deal

October 5, 2011
Research and Development Merck KGaA

Merck KGaA has signed development deals with Japanese firm Ono Pharmaceutical Co around two investigational treatments, one for multiple sclerosis …

News
Merck Serono

Merck licences new MS drug

September 19, 2011
Research and Development Cladribine, Merck KGaA, Merck Serono, PI-2301

Merck KGaA has in-licensed a new multiple sclerosis drug and aims to start it in phase II studies later this …

News

Merck acquires cell imaging instrument maker Amnis

September 1, 2011
Research and Development Merck KGaA, Millipore

EMD Millipore, the Massachussetts-based life sciences arm of Merck KGaA, has bought US cell imaging instrument maker Amnis Corporation for …

News
Merck KGaA

Merck scraps MS pill cladribine

June 23, 2011
Research and Development, Sales and Marketing Cladribine, Merck KGaA, Movectro, multiple sclerosis

Merck KGaA has pulled all pending applications for its multiple sclerosis pill Movectro and will withdraw it from the markets …

News

Merck KGaA readies phase III brain cancer trial

June 13, 2011
Research and Development Merck KGaA, brain cancer, cilengitide, glioblastoma

Merck KGaA has completed patient enrollment for a phase III global trial of its first-in-class integrin inhibitor in a rare …

News
Merck Pharmaceutical Manufacturing (MPM)

Merck KGaA sells South African manufacturing unit

May 10, 2011
Manufacturing and Production Merck KGaA, Merck Pharmaceutical Manufacturing, Merck South Africa

Merck South Africa, a subsidiary of Germany’s Merck KGaA, has sold its manufacturing to a local private equity firm as …

News
Erbitux (cetixumab)

Merck re-submits Erbitux to the EMA for lung cancer

March 30, 2011
Sales and Marketing EGFR, Erbitux, Iressa, Merck KGaA, NSCLC, Tarceva, lung cancer drugs, non-small cell lung cancer

Merck KGaA has re-submitted Erbitux’s lung cancer licence extension to the EMA after its first application to the regulator was …

News
EMD Serono headquarters

FDA knocks back Merck KGaA’s oral MS drug

March 2, 2011
Sales and Marketing Cladribine, EMD Serono, FDA, MS, Merck KGaA, Movectro, multiple sclerosis, oral MS drugs

US authorities have turned down Merck KGaA’s new drug application for its oral relapsing-remitting multiple sclerosis treatment Movectro. The FDA …

News

Friedhelm Felten to head procurement at Merck

March 1, 2011
Manufacturing and Production, Research and Development Friedhelm Felten, Merck KGaA, appointment, manufacturing and production, research and development

Merck KGaA has appointed Friedhelm Felten as its new head of corporate procurement with responsibility for the group’s global purchasing …

Appointment
Merck KGaA

Merck KGaA sales soar

February 21, 2011
Sales and Marketing 2010 pharma results, Cladribine, Merck KGaA, Merck Serono, Movectro

Merck KGaA’s sales jumped last year by nearly a fifth as recent acquisitions and strong growth on core products set …

News
Merck Serono headquarters

Merck Serono halts Movectro European licence application

February 18, 2011
Medical Communications, Sales and Marketing Cladribine, MS, Merck KGaA, Merck Serono, Movectro, fingolimod, gilenya, multiple sclerosis

Merck Serono has withdrawn its European licence application for multiple sclerosis drug Movectro. Movectro (cladribine) is a new oral treatment …

News

Germany’s Merck pledges emphasis on women executives

February 14, 2011
Sales and Marketing Merck KGaA, Women in pharma, equality

Merck KGaA has set itself the goal of increasing its proportion of women managers over the next five years. The …

News

Latest content

GSK shares data from global shingles survey

December 1, 2023

AbbVie to acquire ImmunoGen for approximately $10.1bn

December 1, 2023

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023